Tropical Weather Alert: For the latest updates on closures or modified hours for our UF Health clinical facilities, click here
Clinical trials
-
BT015: Blood-Brain Barrier Disruption (BBBD) Liquid Biopsy in Subjects With GlioBlastoma Brain Tumor The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
- Investigator
- Justin D Hilliard
- Ages
- 18 Years - 80 Years
- Sexes
- All
-
SIJ-01 This is a Phase 1 trial. The overall objective is to evaluate the safety and potential efficacy effect of specific type of umbilical cord blood product (CFL001), which, other than specific modifications in manufacturing to render it compatible with…
- Investigator
- Rene Przkora
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
AL002 Feasibility Study for Treatment of Alzheimer s Disease The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
- Investigator
- Justin D Hilliard
- Ages
- 50 Years - 85 Years
- Sexes
- All